Merck & Co. and Hanwha Chemical to Develop Biosimilar Candidate
06:00 AM | June 14, 2011 | Deepti Ramesh
Merck & Co. (Whitehouse Station, NJ) says it has entered into an exclusive global agreement with Hanwha Chemical (Seoul) to develop and commercialize a candidate biosimilar form of Enbrel (etanercept)...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.